Integrated BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 3, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020 - 2016
Market Capitalization	10	11	6	10	15	33	Upgrade
Market Cap Growth	48.78%	75.42%	-36.28%	-33.74%	-54.33%	146.41%	Upgrade
Enterprise Value	6	9	6	10	19	41	Upgrade
Last Close Price	0.31	0.36	0.21	0.33	0.50	1.10	Upgrade
PE Ratio	14.09	13.72	56.44	-	3.90	4.09	Upgrade
PS Ratio	0.18	0.20	0.13	0.20	0.27	0.52	Upgrade
PB Ratio	0.47	0.55	0.33	0.53	0.81	2.29	Upgrade
P/TBV Ratio	0.47	0.55	0.33	0.53	0.81	2.29	Upgrade
P/FCF Ratio	4.01	5.92	16.21	8.89	4.15	11.90	Upgrade
P/OCF Ratio	3.55	5.37	6.70	8.05	3.66	10.75	Upgrade
EV/Sales Ratio	0.11	0.17	0.13	0.20	0.35	0.64	Upgrade
EV/EBITDA Ratio	1.87	3.96	11.36	21.85	6.31	6.68	Upgrade
EV/EBIT Ratio	3.34	4.59	25.26	85.75	7.08	7.07	Upgrade
EV/FCF Ratio	2.36	4.94	16.26	9.22	5.39	14.84	Upgrade
Debt / Equity Ratio	0.04	0.05	0.09	0.14	0.11	0.42	Upgrade
Debt / EBITDA Ratio	0.25	0.30	1.15	1.91	0.55	0.84	Upgrade
Debt / FCF Ratio	0.32	0.54	4.61	2.39	0.57	2.18	Upgrade
Asset Turnover	2.07	2.13	1.95	2.00	2.22	2.63	Upgrade
Inventory Turnover	4.45	4.74	4.32	4.37	4.37	4.96	Upgrade
Quick Ratio	1.83	2.13	1.04	1.21	0.99	0.66	Upgrade
Current Ratio	4.12	4.42	2.92	3.39	3.16	1.95	Upgrade
Return on Equity (ROE)	3.36%	4.08%	0.59%	-0.18%	23.33%	78.55%	Upgrade
Return on Assets (ROA)	4.09%	4.94%	0.61%	0.30%	6.77%	14.94%	Upgrade
Return on Capital (ROIC)	5.00%	5.96%	0.74%	0.36%	8.38%	19.26%	Upgrade
Return on Capital Employed (ROCE)	8.10%	9.80%	1.20%	0.60%	13.70%	35.70%	Upgrade
Earnings Yield	6.98%	7.29%	1.77%	-0.34%	25.64%	24.44%	Upgrade
FCF Yield	24.94%	16.90%	6.17%	11.25%	24.08%	8.40%	Upgrade
Buyback Yield / Dilution	-1.02%	-0.95%	-3.08%	7.34%	-0.65%	-3.07%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.